Fortrea Holdings Inc. (FTRE) vs Teladoc Health, Inc. (TDOC)
A side-by-side comparison of Fortrea Holdings Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
FTRE
Fortrea Holdings Inc.
$20.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
TDOC
Teladoc Health, Inc.
$5.52HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — FTRE vs TDOC
growth of $100 · dividends reinvested · last 3yFTRE -37.5% (-14.5%/yr)TDOC -78.1% (-39.7%/yr)FTRE compounded faster over this window
FTRE TDOC
FTRE vs TDOC: by the numbers
- •FTRE is the larger company ($1.90B vs $1.00B market cap).
- •Both run net losses; FTRE's is the smaller (-3.18% vs -7.13% net margin).
- •TDOC grew revenue faster over the past five years (8.85% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | FTRE | TDOC |
|---|---|---|
| Forward P/E | 23.78 | N/A |
| P/S ratio | 0.71 | 0.40 |
| P/B ratio | 3.63 | 0.77 |
| EV / EBITDA | 31.92 | 12.45 |
| FCF yield | 7.92% | 22.40% |
Profitability
| Metric | FTRE | TDOC |
|---|---|---|
| Gross margin | 17.11% | 73.53% |
| Operating margin | 0.41% | -6.98% |
| Net margin | -3.18% | -7.13% |
| ROE | -16.25% | -13.54% |
| ROIC | 0.62% | -7.32% |
Growth (annualized)
| Metric | FTRE | TDOC |
|---|---|---|
| Revenue CAGR (5Y) | 1.09% | 8.85% |
| FCF CAGR (5Y) | -12.98% | N/A |
| Total return CAGR (5Y) | N/A | -46.55% |
Frequently asked
- Which has grown faster, FTRE or TDOC?
- Over the past five years, TDOC grew revenue faster — FTRE at a 1.09% CAGR versus TDOC at 8.85%.
Go deeper
Dig into the metrics
Fortrea ROETeladoc Health ROEFortrea operating marginTeladoc Health operating marginFortrea revenue growthTeladoc Health revenue growthFortrea free cash flowTeladoc Health free cash flow
Fortrea & Teladoc Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.